RICHTER TRANSFORMATION
Clinical trials for RICHTER TRANSFORMATION explained in plain language.
Never miss a new study
Get alerted when new RICHTER TRANSFORMATION trials appear
Sign up with your email to follow new studies for RICHTER TRANSFORMATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for tough blood cancers: experimental drug enters human testing
Disease control OngoingThis early-stage trial tests a new drug called BGB-21447 in about 112 people whose B-cell blood cancers (like lymphoma or leukemia) have returned or stopped responding to standard treatments. The main goals are to find a safe dose and check for side effects. Researchers will also…
Matched conditions: RICHTER TRANSFORMATION
Phase: PHASE1 • Sponsor: BeOne Medicines • Aim: Disease control
Last updated May 17, 2026 04:36 UTC
-
Triple-Target CAR T-Cells take on Hard-to-Treat lymphomas
Disease control ENROLLING_BY_INVITATIONThis early-phase study tests a new type of immunotherapy called tri-specific CAR T-cells for people with B-cell lymphomas that have come back or not responded to treatment. The therapy is designed to target three different markers on cancer cells to improve effectiveness and redu…
Matched conditions: RICHTER TRANSFORMATION
Phase: PHASE1 • Sponsor: University of Maryland, Baltimore • Aim: Disease control
Last updated May 11, 2026 20:38 UTC